Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03682536 |
|---|---|
| Brief Title: | A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve (COMMANDS) |
| First Submitted : | September 7, 2018 |
| First Submitted that Met QC Criteria : | September 20, 2018 |
| First Posted : | September 24, 2018 |
| Last Update Submitted that Met QC Criteria : | November 17, 2022 |
| Last Update Posted : | November 21, 2022 |